Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-02

Clinical Trial Update: Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery [NA]

View source ↗

Summary

Completed clinical trial evaluating the effect of dexmedetomidine on quality of recovery (QOR-40) and postoperative nausea and vomiting in breast cancer surgery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Yonsei University | Conditions: Breast Cancer | NA | Status: COMPLETED